BIOSYNTAGMA, LLC
Medtech
Microfluidic platform that combines spatial imaging of tissue with laser-based cell isolation and multi-omic analysis
biosyntagma.com →- Grants
- $1.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 1 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: High multiplex visual mapping of heterogeneity in FFPE biospecimen | $213,904 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: High multiplex visual mapping of heterogeneity in FFPE biospecimen | $892,086 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel method for spatial, multi-omic visualization of single-cell heterogeneity | $196,129 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel method for spatial, multi-omicvisualization of single-cell heterogeneity | $198,129 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel method for spatial, multi-omic visualization of single-cell heterogeneity | $2,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1922 | Innoventric | — | — |
| 1923 | RAPHA ROBOTICS INC | — | — |
| 1924 | IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC | — | — |
| 1925 | BIOSYNTAGMA, LLC | — | — |
| 1926 | WEARABLE DEFENSE LLC | — | — |
| 1927 | SEER, INC. | — | — |
| 1928 | ADDINEX TECHNOLOGIES, INC. | — | $1.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Device and Method for Dissecting and Analyzing Individual Cell Samplesgranted
- Device And Method For Dissecting And Analyzing Individual Cell Samplesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.